Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain

Journal Article · Fri Jul 19 00:00:00 EDT 2019 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.8b00633· OSTI ID:1544831

Bagal, Sharan K.; Andrews, Mark; Bechle, Bruce M.; Bian, Jianwei; Bilsland, James; Blakemore, David C.; Braganza, John F.; Bungay, Peter J.; Corbett, Matthew S.; Cronin, Ciaran N.; Cui, Jingrong Jean; Dias, Rebecca; Flanagan, Neil J.; Greasley, Samantha E.; Grimley, Rachel; James, Kim; Johnson, Eric; Kitching, Linda; Kraus, Michelle L.; McAlpine, Indrawan ; Nagata, Asako; Ninkovic, Sacha; Omoto, Kiyoyuki; Scales, Stephanie; Skerratt, Sarah E.; Sun, Jianmin; Tran-Dubé, Michelle; Waldron, Gareth J.; Wang, Fen; Warmus, Joseph S. ^[1]

---

1. Pfizer

• Research Organization: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
• Sponsoring Organization: INDUSTRY
• OSTI ID: 1544831
• Journal Information: J. Med. Chem., Vol. 61, Issue (15) ; 08, 2018
• Country of Publication: United States
• Language: ENGLISH